To investigate if the decreased expression of PD-1, TIM3 and LAG3 on CD8+ T cells induced by ibrutinib was due to pre-existing CLL patient T cell exhaustion, the effects of BTKi on the proliferation of healthy donor cells was analysed. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.